8-A12B

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

Privia Health Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   85-3599420
(State of Incorporation or Organization)   (I.R.S. Employer Identification No.)

950 N. Glebe Road

Suite 700

Arlington, Virginia

  22203
(Address of Principal Executive Offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class
to be so Registered

 

Name of Each Exchange on Which
Each Class is to be Registered

Common Stock, par value $0.01 per share   The Nasdaq Global Select Market

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  ☒:

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ☐

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.  ☐

Securities Act registration statement file number to which this form relates:

333-255086

(If applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

(Title of Class)

N/A

 

 

 


Item 1:

Description of Registrant’s Securities to be Registered

The description under the heading “Description of Capital Stock” relating to the Registrant’s common stock, par value $0.01 per share (the “Common Stock”), in the prospectus included in the Registrant’s Registration Statement on Form S-1 (Registration No. 333-255086) originally filed with the Securities and Exchange Commission on April 7, 2021, as amended (the “Registration Statement”), is incorporated by reference herein. In addition, the description that will be included under the heading “Description of Capital Stock” relating to the Common Stock in the Registrant’s final prospectus relating to the Registration Statement to be subsequently filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be incorporated by reference herein.

 

Item 2:

Exhibits

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Global Select Market and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Privia Health Group, Inc.
By:  

/s/ Thomas Bartrum

  Name:   Thomas Bartrum
  Title:   Chief Executive Officer

Date: April 26, 2021